SEC accuses Biotech VC of siphoning funds

By Ross Todd, From The Recorder SAN FRANCISCO — Prominent biotech venture capitalist G. Steven Burrill has agreed to pay nearly $5.8 million to settle charges that he redirected money from one of his funds to prop up other flagging investments…